Cochlear (COH)

The share price of hearing implant maker
Cochlear
has been on a rising trend since March on expectations of continued growth as it recovers from a major product recall last September. On Tuesday, its share price was trading around $65, which is still off from the highs of $76.79 reached in late August, before it announced the product recall. However, if current momentum in its share price is maintained, it won’t be long before it catches up with the highs of pre-recall levels. One of Cochlear’s major shareholders, Hyperion Asset Management, increased its holding in Cochlear during April, while June saw American Investment Management firm Harding Loevner purchase a substantial shareholding. Yet clouds remain on the horizon, with Cochlear in the process of defending a patent infringement complaint in a US court. The complaint was filed by a US firm against Cochlear’s American subsidiary. Qaiser Mailk